Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Lymphoma 306Lymphoma, Follicular 268Lymphoma, Non-Hodgkin 170Leukemia 138Hodgkin Disease 135Multiple Myeloma 130Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Large B-Cell, Diffuse 108Leukemia, Myeloid, Acute 98Neoplasms 83Lymphoma, Mantle-Cell 70Burkitt Lymphoma 70Myelodysplastic Syndromes 64Breast Neoplasms 62Lymphoma, T-Cell, Cutaneous 60Lymphoma, B-Cell, Marginal Zone 59Myeloproliferative Disorders 50Mycosis Fungoides 50Motor Activity 49Lymphoma, Large-Cell, Immunoblastic 47Sezary Syndrome 44Neoplasms, Plasma Cell 42Hematologic Neoplasms 41Dementia 41Primary Myelofibrosis 39Leukemia, Myeloid, Chronic-Phase 38Leukemia, Myeloid, Accelerated Phase 38Congenital Abnormalities 38Recurrence 37

Interventions

Propofol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Emergence Delirium × Lymphoid × Clear all
NCT03528954 2019-02-06

Propofol to Reduce the Incidence of Postanesthetic Emergence Agitation in Pediatric Patients Under General Anesthesia

Indonesia University

Phase NA Completed
54 enrolled
LymphoidOther hematologic neoplasm

Emergence Delirium, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡